New era in cholesterol treatment: Gene editing and RNA drugs show promise beyond statins

Daijiworld Media Network – New York

New York, Nov 11: For decades, statins like Lipitor and Zocor have been the cornerstone of cholesterol management. But as experts note, they don’t work for everyone — and now, a new wave of advanced therapies is transforming the field of heart disease prevention.

At the American Heart Association’s annual meeting this weekend, researchers presented groundbreaking studies on novel cholesterol-lowering drugs, including RNA-based injections, PCSK9 inhibitors, and gene-editing therapies. These treatments promise to go beyond the limits of traditional statins in cutting harmful LDL, or “bad,” cholesterol.

Pharmaceutical giant Merck reported strong results for its experimental PCSK9 pill, which reduced LDL cholesterol by up to 60% in six months during late